Fox Chase Cancer Center News

PHILADELPHIA (October 4, 2018) – Jose Russo, MD, FACP, director of the Irma H. Russo, MD, Breast Cancer Research Lab at Fox Chase Cancer Center, named by AL DÍA as one of nine recipients of their Hispanic Heritage Award for 2018.

PHILADELPHIA (October 2, 2018) — Observing how cells of the intestinal epithelium respond to Salmonella, scientists at Fox Chase Cancer Center have found a novel mechanism of cell death that shows a way to control the spread of bacteria.

PHILADELPHIA (October 2, 2018) – Fox Chase Cancer Center will again field a team  to raise funds at the Pancreatic Cancer Action Network (PanCAN) PurpleStride Philadelphia. The event will be held on Saturday, November 3 at Memorial Hall in Fairmount Park.

PHILADELPHIA (October 1, 2018) – October is Breast Cancer Awareness month. Fox Chase Cancer Center reminds women to schedule their screening test for breast cancer—the most reliable way to detect breast cancer early, when the disease is most treatable.

Philadelphia (September 28, 2018) – Fox Chase Cancer Center is pleased to announce that its scientists and clinicians earned several newly issued patents during fiscal years 2017 and 2018, the latter of which ended June 30, 2018.

PHILADELPHIA (September 25, 2018)— In addition to impacting cancer risk, mutations in the BRCA1 gene also have a role in determining whether a patient responds to certain types of therapies. In a new publication, Neil Johnson, PhD, found that cancers with different types of BRCA1 mutations have varying susceptibilities to biological pathways that induce resistance to PARP inhibitors, an emerging class of cancer drugs

PHILADELPHIA (August 23, 2018) – Alexander Kutikov, MD, FACS, chief, Division of Urology and Urologic Oncology at Fox Chase Cancer Center, has been named August’s Everyday Hero by the Pennsylvania Medical Society (PAMED). The award is designed to showcase talented physicians who probably don’t view themselves as heroes, but to patients and colleagues they are.

PHILADELPHIA (September 21, 2018)— On September 21, Vice President Joe Biden and Dr. Jill Biden are hosting the National Biden Cancer Summit in Washington, D.C., to drive the urgency of now by promoting new solutions, bringing together problem solvers, and telling stories that epitomize what it means to be cancer FIERCE. The Life Raft Group will announce a new initiative to strengthen and advance research for effective treatments of a rare subset of Gastrointestinal Stromal Tumor (GIST) patients who have been unresponsive to the current standard treatments.